艾司洛尔减轻腹腔感染早期脓毒症大鼠的细胞凋亡与炎症
本研究为动物实验,将大鼠随机分为假手术组、脓毒症组、抗生素组及艾司洛尔(低、中、高剂量)联合抗生素组。结果显示,艾司洛尔各组肝、肾炎症浸润病理表现减轻,Bcl-2 mRNA及蛋白水平升高、Bax降低,血清IL-6、HMGB-1、TNF-α降低而IL-10升高,心肌酶水平低于脓毒症组和抗生素组。作者认为早期脓毒症使用艾司洛尔可能减轻炎症、抑制凋亡并保护关键器官。
要点
- 在腹腔感染早期脓毒症大鼠中,艾司洛尔低、中、高剂量联合抗生素组肝、肾炎症浸润病理表现较脓毒症组减轻。
- 艾司洛尔各组肝、肾Bcl-2 mRNA及蛋白水平升高,Bax mRNA及蛋白水平降低。
- 艾司洛尔各组血清IL-6、HMGB-1、TNF-α水平较脓毒症组降低,IL-10水平升高。
- 与脓毒症组和抗生素组相比,艾司洛尔低、中、高剂量组心肌酶水平更低。
- 作者认为早期脓毒症使用艾司洛尔可能减轻炎症、抑制凋亡并保护关键器官。
适用人群与场景
- 腹腔感染早期脓毒症大鼠模型。
研究设计与关键结果
- 研究类型为动物实验,大鼠随机分为假手术组、脓毒症组、抗生素组及艾司洛尔低、中、高剂量联合抗生素组。
- 肝、肾组织:脓毒症组可见炎症浸润,艾司洛尔低、中、高剂量组病理表现减轻。
- 肝、肾组织:艾司洛尔低、中、高剂量组Bcl-2 mRNA及蛋白水平升高,Bax mRNA及蛋白水平降低。
- 血清:与脓毒症组相比,艾司洛尔低、中、高剂量组IL-6、HMGB-1、TNF-α水平降低,IL-10水平升高。
- 心肌酶:与脓毒症组和抗生素组相比,艾司洛尔低、中、高剂量组水平更低。
证据类型、等级与局限
- 证据类型:动物实验(大鼠)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Esmolol is a highly selective beta 1 receptor blocker with various effects such as slowing heart rate, lowering blood pressure and reducing myocardial oxygen consumption. However, few studies have reported the use of beta blockers in sepsis with multiple organ dysfunctions. This study aimed to investigate the effects of esmolol on reducing apoptosis and inflammation in early sepsis rats with abdominal infection.
METHODS: Rats were randomly divided into sham operation group, sepsis group, antibiotic group, Esmolol + antibiotic group with low, median and high dose Esmolol (L group, M group and H group). Values between two or more groups were compared by independent t-tests.
RESULTS: In the liver and kidney, we found inflammatory infiltration in sepsis group while pathological aspects reduced in L, M and H groups. Bcl-2 mRNA and protein levels increased while Bax mRNA and protein levels decreased in the liver and kidney of L, M and H groups. Serum IL-6, HMGB-1 and TNF-α levels decreased but IL-10 level increased in L, M and H groups, compared to sepsis group. Compared to sepsis and antibiotic groups, the levels of myocardial enzymes were lower in L, M and H groups.
CONCLUSION: The administration of esmolol in early sepsis may reduce inflammation, inhibit apoptosis and protect key organs.
参考来源
- Lu Y, Yang Y, He X, et al. Esmolol reduces apoptosis and inflammation in early sepsis rats with abdominal infection. Am J Emerg Med. 2017. PMID: 28457762. doi:10.1016/j.ajem.2017.04.056
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。